Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Thursday that its Q1 revenues rose 23 percent year over year.

For the three months ended March 31, total revenues were $18.1 million compared to $14.7 million in the prior year period, beating the average Wall Street analyst estimate of $17.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.